Talphera (TLPH) Research & Development (2010 - 2026)
Talphera (TLPH) posted quarterly Research & Development of $1.6 million for Q1 2026, up 41.15% year-over-year from $1.2 million in Q1 2025, and up 5.7% quarter-over-quarter from $1.6 million in Q4 2025.
Talphera (TLPH) Research & Development (2010 - 2026) Analysis & Trends
Talphera's Research & Development history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Research & Development rose 41.15% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $6.5 million (up 0.93% YoY), while the FY2025 annual figure was $6.0 million, down 10.2% from the prior year.
- Research & Development for Q1 2026 stood at $1.6 million, up from $1.6 million in the prior quarter.
- The five-year high for Research & Development was $2.1 million in Q3 2024, with the low at $612000.0 in Q4 2022.
- The 5-year median for Research & Development is $1.5 million (2024), against an average of $1.4 million.
- The sharpest annual moves came in 2022 and 2023: Research & Development slumped 43.57% in 2022, then jumped 189.05% in 2023.
- Talphera's Research & Development stood at $612000.0 in 2022, then surged by 189.05% to $1.8 million in 2023, then slipped by 25.21% to $1.3 million in 2024, then increased by 17.99% to $1.6 million in 2025, then gained by 5.7% to $1.6 million in 2026.
- Business Quant data shows TLPH's Research & Development at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Talphera | 89.12 Mn | 89.12 Mn | - | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.69 Mn |
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Dec 31, 2022 | 612,000.00 |
| Sep 30, 2022 | 799,000.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 986,000.00 |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 724,000.00 |